Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Industry News

Related Searches:

Filter by:

January 8, 2009
UPS has been selected by Merck to manage a significant portion of its U.S. distribution of pharmaceuticals and vaccines as well as to provide package transportation services. Through its subsidiary, UPS Supply Chain Solutions, UPS has assumed control…   Read More »
January 7, 2009
Keata Pharma, a subsidiary of PharmEng International, has signed an agreement with an undisclosed global consumer healthcare company for the manufacture of branded non-prescription drug products for Canada and other international territories. This ne…   Read More »
January 7, 2009
Akrimax Pharmaceuticals has entered a manufacturing agreement for the production of pharmaceutical products for an undisclosed global company. Akrimax will begin production in 2009.       Akrimax president Alan L. Rubino…   Read More »
December 31, 2008
Nektar Therapeutics has sold some of its pulmonary delivery assets, technology, and intellectual property to Novartis for $115 million in cash. Novartis now owns "certain dry powder and liquid pulmonary formulation and manufacturing assets, incl…   Read More »
December 30, 2008
Actavis Inc. has reached agreement with the FDA on a Consent Decree of Permanent Injunction the company’s Actavis Totowa LLC subsidiary. This agreement, in effect, settles the issues identified by the Department of Justice in its previously fil…   Read More »
December 19, 2008
PharmaNet Development Group is working with a financial advisor to pursue strategic alternatives, including the potential sale of the company. “The Board of Directors and management believe that pursuing strategic alternatives will maximize sha…   Read More »
December 19, 2008
Oncothyreon Inc. has announced plans to restructure and focus on development of two compounds, PX-478 and PX-866. PX-478 is an inhibitor of hypoxia inducible factor-1 alpha that is currently in a Phase I trial for advanced metastatic cancer and lymph…   Read More »
December 18, 2008
Wyeth has acquired Thiakis Limited, a privately held biotechnology company based in the United Kingdom. Thiakis' lead product candidate, TKS1225, is being studied for the treatment of medical obesity and other co-morbidities. TKS1225 and related comp…   Read More »
December 17, 2008
Covance has purchased a minority equity stake in Caprion Proteomics, a  provider of proteomics-based services. Covance has also hired a new vice president to lead its Biomarker team and that it plans to establish a Biomarker Center of Excellence…   Read More »
December 17, 2008
PPD, Inc. plans to expand its global central lab services into Singapore in response to growing demand in Southeast Asia. The lab is expected to begin operations in mid-2009 and will provide biopharmaceutical clients with a "comprehensive range…   Read More »
December 16, 2008
Quotient Bioscience Group Ltd. has acquired Pharmaceutical Profiles Group (PPG), which will be integrated into Quotient Bioresearch. Founded in 1990, Pharmaceutical Profiles is a  provider of Phase I drug development services to the global pharm…   Read More »
December 16, 2008
Jazz Pharmaceuticals has fired 71 employees (24% of its work force) to lower operating expenses. The company expects to record a charge of approximately $1.9 million in 4Q08 related to the move. Separately, the company's chief financial officer, Matt…   Read More »
December 12, 2008
Elan Corp. will realign itself to focus more resources on its pipeline. Concrete plans have not been released, but the company plans to cut a number of positions and "additional refinement to Elan’s commercial activities in Tysabri for Cro…   Read More »
December 10, 2008
Almac Clinical Services completed a successful inspection of its Durham, NC operations by the UK Medicines and Healthcare products Regulatory Agency (MHRA). This marked the final inspection covering the group’s main sites for clinical supplies…   Read More »
December 10, 2008
Patheon has opened its new U.S. headquarters and analytical lab facilities in the vicinity of Research Triangle Park (RTP), NC. The new pharmaceutical development laboratory will support Patheon's current U.S.-based pharmaceutical development operati…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On